Aspergillus pleural empyema in a chronic smoker - A case report and review of literature

J Mycol Med. 2022 Nov;32(4):101299. doi: 10.1016/j.mycmed.2022.101299. Epub 2022 May 23.

Abstract

Aspergillus species are ubiquitous saprophytic fungi that are present in the air, water, soil, and decaying vegetables. Clinical features of Aspergillus infection largely depend on the interplay between the fungi and the host immune status. We present a case of a chronic smoker with shortness of breath who was found to have diffuse bronchiectatic changes and empyema of the right lung. Emphysema was also noticed in the left lung. Rare Aspergillus fumigatus was identified in the pleural fluid, while the acid-fast stain and bacterial cultures were negative. The patient's serum Aspergillus fumigatus IgG antibody and galactomannan antigen were negative; however, the pleural galactomannan antigen was elevated. He was treated with video-assisted thoracoscopic surgery (VATS) and partial decortication of the right lung, along with intravenous voriconazole. Despite aggressive therapeutic measures, he died after a prolonged hospital stay. Aspergillus pleural empyema is rare but can be fatal; however, it is not included in the classification for pulmonary aspergillosis. Clinicians should be vigilant to evaluate for fungal empyema in patients with chronic obstructive pulmonary diseases, even without profound immunosuppression.

Keywords: Asgergillus fumigatus; Aspergillosis; COPD; Case report; Empyema.

Publication types

  • Review
  • Case Reports

MeSH terms

  • Aspergillosis* / complications
  • Aspergillosis* / diagnosis
  • Aspergillosis* / drug therapy
  • Aspergillus
  • Empyema, Pleural* / diagnosis
  • Empyema, Pleural* / drug therapy
  • Empyema, Pleural* / microbiology
  • Humans
  • Male
  • Smokers
  • Voriconazole / therapeutic use

Substances

  • Voriconazole